The increased level of Pon1 expression in cardiac tissue during obesity in this study indicates an increase in local inflammation in cardiac tissue, necessitating more Pon1 to maintain normal myocardial function, whereas the decreased level of Pon1 expression after empagliflozin administration indicates a decrease in cardiac tissue inflammation. Here, PON1 is linked to obesity due to melanocortin 4 receptor deficiency.